Cancer Research and Treatment

Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice

Hae Young Kim, Seung Hyun Cho, Jong Keon Jang, Bohyun Kim, Chul-min Lee, Joon Seok Lim, Sung Kyoung Moon, Soon Nam Oh, Nieun Seo, Seong Ho Park

Korean Journal of Radiology.2024; 25(4): 351. CrossRef

Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches

Gizem Kaval, Merve Gulbiz Dagoglu Kartal, Sena Azamat, Eda Cingoz, Gokhan Ertas, Sule Karaman, Basak Kurtuldu, Metin Keskin, Neslihan Berker, Senem Karabulut, Ethem Nezih Oral, Nergiz Dagoglu Sakin

A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors

Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hung, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, K.S. Clifford Chao

Cancer Immunology Research.2023; 11(1): 123. CrossRef

Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?

Martin Svoboda, Vladimír Procházka, Tomáš Grolich, Tomáš Pavlík, Monika Mazalová, Zdeněk Kala

Journal of Gastrointestinal Cancer.2023; 54(2): 528. CrossRef

MRI‐Based Artificial Intelligence in Rectal Cancer

Chinting Wong, Yu Fu, Mingyang Li, Shengnan Mu, Xiaotong Chu, Jiahui Fu, Chenghe Lin, Huimao Zhang

Journal of Magnetic Resonance Imaging.2023; 57(1): 45. CrossRef

Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue

Tamara Babic, Vasiliki Lygirou, Jovana Rosic, Marko Miladinov, Aleksandra Djikic Rom, Eirini Baira, Rafael Stroggilos, Eftychia Pappa, Jerome Zoidakis, Zoran Krivokapic, Aleksandra Nikolic

PROTEOMICS – Clinical Applications.2023;[Epub] CrossRef

Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy

Zhengwu Tan, Lan Cheng, Lingling Xie, Lan Zhang, Zhenyu Lin, Ping Han, Xin Li

Asia-Pacific Journal of Clinical Oncology.2023; 19(3): 327. CrossRef

Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy

Emese Sarolta Bádon, Lívia Beke, Attila Mokánszki, Csilla András, Gábor Méhes

International Journal of Molecular Sciences.2023; 24(3): 2581. CrossRef

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy

Hyun Jin Bang, Hyun Jeong Shim, Jun Eul Hwang, Woo Kyun Bae, Ik Joo Chung, Sang Hee Cho

The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma

Topias Karjula, Niko Kemi, Anne Niskakangas, Olli Mustonen, Iiris Puro, Vesa-Matti Pohjanen, Teijo Kuopio, Hanna Elomaa, Maarit Ahtiainen, Jukka-Pekka Mecklin, Toni T. Seppälä, Erkki-Ville Wirta, Eero Sihvo, Juha P. Väyrynen, Fredrik Yannopoulos, Olli Hel

European Journal of Surgical Oncology.2023; 49(7): 1298. CrossRef

An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate

Supparerk Laohawiriyakamol, Wongsakorn Chaochankit, Worawit Wanichsuwan, Kanet Kanjanapradit, Teeranan Laohawiriyakamol

Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer

Anqi Wang, Jieli Zhou, Gang Wang, Beibei Zhang, Hongyi Xin, Haiyang Zhou

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation

Jingjing Wu, Mingzhe Huang, Yuanhui Wu, Yisong Hong, Linbin Cai, Rongzhao He, Yanxin Luo, Puning Wang, Meijin Huang, Jinxin Lin

Journal of Cancer Research and Clinical Oncology.2023; 149(11): 8897. CrossRef

A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study

Yihan Wu, Xiaohua Liu, Fang Liu, Yi Li, Xiaomin Xiong, Hao Sun, Bo Lin, Yu Li, Bo Xu

Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients

Caterina Foppa, Annalisa Maroli, Antonio Luberto, Carlotta La Raja, Paola Spaggiari, Cristiana Bonifacio, Stefano De Zanet, Marco Montorsi, Salvatore Piscuoglio, Luigi Maria Terracciano, Armando Santoro, Antonino Spinelli

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

I-Li Lai, Jeng-Fu You, Wen-Sy Tsai, Yu-Jen Hsu, Yih-Jong Chern, Ming-Ying Wu

World Journal of Surgical Oncology.2023;[Epub] CrossRef

Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis

De-xing Zeng, Zhou Yang, Ling Tan, Meng-ni Ran, Zi-lin Liu, Jiang-wei Xiao

Clinical predictors of rectal cancer response after neo-adjuvant (Chemo)Radiotherapy in Australia and New Zealand: Analysis of the Bi-National Colorectal Cancer Audit (BCCA)

Jianliang Liu, Justin Y.T. Lee, Sergei Bedrikovetski, Luke Traeger, James W. Moore, Joanne L. Perry, Hidde M. Kroon, Tarik Sammour

European Journal of Surgical Oncology.2023; 49(11): 107070. CrossRef

Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series

Domenico Pinelli, Andrea Micalef, Barbara Merelli, Rosangela Trezzi, Annalisa Amaduzzi, Stefano Agnesi, Michela Guizzetti, Stefania Camagni, Veronica Fedele, Michele Colledan

Cancer Treatment and Research Communications.2023; 37: 100770. CrossRef

The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0

Yujun Cui, Xinzhi Liu, Shuai Li, Hongzhi Wang, Yirong Xiang, Yangzi Zhang, Maxiaowei Song, Jianhao Geng, Zhiyan Liu, Huajing Teng, Xianggao Zhu, Yong Cai, Yongheng Li, Weihu Wang

Clinical and Translational Oncology.2023; 26(4): 1012. CrossRef

Grading der Tumorregression gastrointestinaler Karzinome nach neoadjuvanter Therapie

Deeper sections reveal residual tumor cells in rectal cancer specimens diagnosed with pathological complete response following neoadjuvant treatment

Lasse Slumstrup, Susanne Eiholm, Astrid Louise Bjørn Bennedsen, Dea Natalie Munch Jepsen, Ismail Gögenur, Anne-Marie Kanstrup Fiehn

MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy

Jaeseung Shin, Nieun Seo, Song-Ee Baek, Nak-Hoon Son, Joon Seok Lim, Nam Kyu Kim, Woong Sub Koom, Sungwon Kim

Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer

Laureline Lamy, Jacques Thomas, Agnès Leroux, Jean-François Bisson, Kari Myren, Aslak Godal, Gry Stensrud, Lina Bezdetnaya

High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates

Serdar Karakaya, İbrahim Karadağ, Mehmet Emin Yılmaz, Ömür Berna Çakmak Öksüzoğlu

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy

Dea Natalie Munch Jepsen, Henrik Høeg, Jeppe Thagaard, Julie Sparholt Walbech, Ismail Gögenur, Anne-Marie Kanstrup Fiehn

Journal of Pathology Informatics.2022; 13: 100152. CrossRef

The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression

Fengpeng Wu, Xiaoxiao Zhang, Congrong Yang, Kanghua Wang, Linlin Xiao, Chaoxi Zhou, Xinming Zhao, Guiying Wang

Reduced field-of-view versus full field-of-view diffusion-weighted imaging for the evaluation of complete response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Siwon Jang, Jeong Min Lee, Jeong Hee Yoon, Jae Seok Bae

Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer

Peige Zhou, Paolo Goffredo, Timothy Ginader, Dakota Thompson, Jennifer Hrabe, Irena Gribovskaja‐Rupp, Muneera Kapadia, Imran Hassan

Journal of Surgical Oncology.2021; 123(1): 278. CrossRef

Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation

Can the mesorectal fat tissue volume be used as a predictive factor in foreseeing the response to neoadjuvant chemoradiotherapy in rectum cancer? A CT-based preliminary study

Okan Dilek, Huseyin Akkaya, Cenk Parlatan, Tolga Koseci, Zeynel Abidin Tas, Gökhan Soker, Bozkurt Gulek

Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival

Jason On, Joanna Shim, Craig Mackay, Graeme Murray, Leslie Samuel, Craig Parnaby, George Ramsay

Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review

K. Wilson, M. Flood, V. Narasimhan, T. Pham, S. Warrier, R. Ramsay, M. Michael, A. Heriot

European Journal of Surgical Oncology.2021; 47(8): 1862. CrossRef

Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience

Paola Germani, Francesca Di Candido, Daniel Léonard, Dajana Cuicchi, Ugo Elmore, Marco Ettore Allaix, Vittoria Pia Barbieri, Laura D’Allens, Seraina Faes, Marika Milani, Damiano Caputo, Carmen Martinez, Jan Grosek, Valerio Caracino, Niki Christou, Sapho X

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study

Yanting Liang, Yaxi Zhu, Huan Lin, Shenyan Zhang, Suyun Li, Yanqi Huang, Chen Liu, Jinrong Qu, Changhong Liang, Ke Zhao, Zhenhui Li, Zaiyi Liu

Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?

Pathology - Research and Practice.2021; 226: 153608. CrossRef

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation

Zhengfa Xue, Shuxin Yang, Yun Luo, Hao Cai, Ming He, Youping Ding, Lei Lei, Wei Peng, Guini Hong, You Guo

Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Tomoyuki Momma, Hirokazu Okayama, Yasuyuki Kanke, Satoshi Fukai, Hisashi Onozawa, Shotaro Fujita, Wataru Sakamoto, Motonobu Saito, Shinji Ohki, Koji Kono

Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey

Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer

Toshiki Mukai, Keisuke Uehara, Toshisada Aiba, Atsushi Ogura, Toyonori Tsuzuki, Aya Tanaka, Masanori Sando, Noriyuki Ohara, Yusuke Sato, Norifumi Hattori, Goro Nakayama, Yasuhiro Kodera, Masato Nagino

The Effect of Lymph Nodes’ Histologic Response on Survival Outcomes in Moroccan Patients with Rectal Cancer

Ihsane El Otmani, Fatima El Agy, Mohammed El Abkari, Karim Ibn Majdoub Hassani, Khalid Mazaz, El Bachir Benjelloun, Khalid Ait Taleb, Touria Bouhafa, Zineb Benbrahim, Sidi Adil Ibrahimi, Laila Chbani

International Journal of Surgical Oncology.2020; 2020: 1. CrossRef

Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus

Flávio Roberto Takeda, Francisco Tustumi, Carlos de Almeida Obregon, Gustavo Gonçalves Yogolare, Yasmin Peres Navarro, Vanderlei Segatelli, Rubens Antonio Aissar Sallum, Ulysses Ribeiro Junior, Ivan Cecconello

Annals of Surgical Oncology.2020; 27(4): 1241. CrossRef

Standardized Pathology Report for Colorectal Cancer, 2nd Edition

Baek-hui Kim, Joon Mee Kim, Gyeong Hoon Kang, Hee Jin Chang, Dong Wook Kang, Jung Ho Kim, Jeong Mo Bae, An Na Seo, Ho Sung Park, Yun Kyung Kang, Kyung-Hwa Lee, Mee Yon Cho, In-Gu Do, Hye Seung Lee, Hee Kyung Chang, Do Youn Park, Hyo Jeong Kang, Jin Hee So

Journal of Pathology and Translational Medicine.2020; 54(1): 1. CrossRef

Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer

Jason K. Douglas, Rose E. Callahan, Zachary A. Hothem, Craig S. Cousineau, Samer Kawak, Bryan J. Thibodeau, Shelli Bergeron, Wei Li, Claire E. Peeples, Harry J. Wasvary

Molecular & Cellular Oncology.2020; 7(3): 1716618. CrossRef

53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer

Ai Huang, Yong Xiao, Chunfen Peng, Tao Liu, Zhenyu Lin, Qin Yang, Tao Zhang, Jun Liu, Hong Ma

Strahlentherapie und Onkologie.2020; 196(5): 465. CrossRef

Predictors of pathological response and clinical outcome following chemoradiation for locally advanced rectal cancer — a systematic review

Erica Amaral, Maria Bernardes, Sara Ribeiro, Beatriz Rosa, Ana Pereira, Sandra F. Martins

Journal of Coloproctology.2020; 40(03): 278. CrossRef

The effect of radiotherapy on rectal cancer: a histopathological appraisal and prognostic indicators

Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial

Mahdi Aghili, Nastaran Khalili, Neda Khalili, Mohammad Babaei, Farshid Farhan, Peiman Haddad, Samaneh Salarvand, Amir Keshvari, Mohammad Sadegh Fazeli, Negin Mohammadi, Reza Ghalehtaki

Radiation Oncology Journal.2020; 38(2): 119. CrossRef

Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study

Bianca Petresc, Andrei Lebovici, Cosmin Caraiani, Diana Sorina Feier, Florin Graur, Mircea Marian Buruian

Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

Siyi Lu, Zhenzhen Liu, Xin Zhou, Bingyan Wang, Fei Li, Yanpeng Ma, Wendong Wang, Junren Ma, Yuxia Wang, Hao Wang, Wei Fu

Cancer Management and Research.2020; Volume 12: 8555. CrossRef

Staging of Locally Advanced Rectal Cancer Beyond TME

Clinics in Colon and Rectal Surgery.2020; 33(05): 258. CrossRef

Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy

Marek Osecky, Dino Kröll, Marcus Feith, Daniel Reim, Bastian Dislich, Karen Becker, Rupert Langer

Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer

World Journal of Gastroenterology.2020; 26(44): 7022. CrossRef

MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance

Frederike Butz, Ann-Kathrin Eichelmann, George C. Mayne, Tingting Wang, Isabell Bastian, Karen Chiam, Shashikanth Marri, Pamela J. Sykes, Bas P. Wijnhoven, Eelke Toxopeus, Michael Z. Michael, Christos S. Karapetis, Richard Hummel, David I. Watson, Damian

International Journal of Molecular Sciences.2020; 21(23): 8898. CrossRef

Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer

Heyu Song, Jiping Zeng, Shrabasti Roychoudhury, Pranjal Biswas, Bhopal Mohapatra, Sutapa Ray, Kayvon Dowlatshahi, Jing Wang, Vimla Band, Geoffrey Talmon, Kishor K. Bhakat

Molecular Cancer Therapeutics.2020; 19(1): 258. CrossRef

Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy

Jung Wook Huh, Hee Cheol Kim, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Chul Park, Doo Ho Choi, Joon Oh Park, Young Suk Park, Ho-Kyung Chun

Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial

Johan Erlandsson, Ester Lörinc, Madelene Ahlberg, David Pettersson, Torbjörn Holm, Bengt Glimelius, Anna Martling

Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy

Kwang-Seop Song, Dong Woon Lee, Bun Kim, Bo Yun Hur, Min Jung Kim, Min Ju Kim, Chang Won Hong, Sung Chan Park, Hyoung-Chul Park, Dae Kyung Sohn, Byung Chang Kim, Kyung Su Han, Jae Hwan Oh

A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma

Zahra Kassam, Kyle Burgers, Joanna C. Walsh, Ting-Yim Lee, Hon S. Leong, Barbara Fisher

Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer

Aijie Li, Kewen He, Dong Guo, Chao Liu, Duoying Wang, Xiangkui Mu, Jinming Yu

Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis

Giuseppe N. Fanelli, Fotios Loupakis, Elizabeth Smyth, Marco Scarpa, Sara Lonardi, Salvatore Pucciarelli, Giada Munari, Massimo Rugge, Nicola Valeri, Matteo Fassan

International Journal of Surgical Pathology.2019; 27(8): 816. CrossRef

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer

Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy

Qunsheng Huang, Huabo Qin, Jian Xiao, Xiaosheng He, Minghao Xie, Xin He, Qiuqiong Yao, Ping Lan, Lei Lian

Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma

M. L. Sánchez de Molina, C. Díaz del Arco, P. Vorwald, D. García-Olmo, L. Estrada, M. J. Fernández-Aceñero

Clinical and Translational Oncology.2018; 20(2): 253. CrossRef

Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy

Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08)

Roger von Moos, Dieter Koeberle, Sabina Schacher, Stefanie Hayoz, Ralph C. Winterhalder, Arnaud Roth, György Bodoky, Panagiotis Samaras, Martin D. Berger, Daniel Rauch, Piercarlo Saletti, Ludwig Plasswilm, Daniel Zwahlen, Urs R. Meier, Pu Yan, Paola Izzo,

A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers

You Guo, Weizhong Jiang, Lu Ao, Kai Song, Huxing Chen, Qingzhou Guan, Qiao Gao, Jun Cheng, Huaping Liu, Xianlong Wang, Guoxian Guan, Zheng Guo

Radiotherapy and Oncology.2018; 129(1): 149. CrossRef

Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings

Min Ju Kim, Bo Yun Hur, Eun Sun Lee, Boram Park, Jungnam Joo, Min Jung Kim, Sung Chan Park, Ji Yeon Baek, Hee Jin Chang, Dae Yong Kim, Jae Hwan Oh, Ju-Seog Lee

Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer

J K Jang, J L Lee, S H Park, H J Park, I J Park, J H Kim, S H Choi, J Kim, C S Yu, J C Kim

British Journal of Surgery.2018; 105(12): 1671. CrossRef

Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer

Karina Vychnevskaia, Frederic Dumont, Julie Agostini, Catherine Julié, Peggy Dartigues, Thierry Lazure, Valérie Boige, Diane Goéré, Antoine Brouquet, Christophe Penna, Frédérique Peschaud, Stéphane Benoist

Annals of Surgical Oncology.2017; 24(5): 1304. CrossRef

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer

Delphine Dayde, Ichidai Tanaka, Rekha Jain, Mei Tai, Ayumu Taguchi

International Journal of Molecular Sciences.2017; 18(3): 573. CrossRef

Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy

Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Giuliana Pagliani, Elisabetta Mattioli, Valeria Barresi

Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer

Tarkan Jäger, Daniel Neureiter, Romana Urbas, Eckhard Klieser, Wolfgang Hitzl, Klaus Emmanuel, Adam Dinnewitzer

Diseases of the Colon & Rectum.2017; 60(8): 815. CrossRef

Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer

Dae Kyung Sohn, Kyung Su Han, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Ji Yeon Baek, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Dae Yong Kim

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?

Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Valeria Barresi

World Journal of Gastroenterology.2017; 23(8): 1412. CrossRef

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy

Ombretta Repetto, Valli De Re, Antonino De Paoli, Claudio Belluco, Lara Alessandrini, Vincenzo Canzonieri, Renato Cannizzaro

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers

You Guo, Jun Cheng, Lu Ao, Xiangyu Li, Qingzhou Guan, Juan Zhang, Haidan Yan, Hao Cai, Qiao Gao, Weizhong Jiang, Zheng Guo

Analysis of long-term outcomes and application of the tumor regression grading system in the therapeutic assessment of resectable limited-disease small cell lung cancer

Shuonan Xu, Jianfei Zhu, Yawei Dou, Wei Tian, Yun Dai, Xianghui Luo, Hongtao Wang

Oncology and Translational Medicine.2016; 2(5): 227. CrossRef